Table 2.
Characteristics of lumbar spine spondylosis and discopathy in patients with OSA and controls.
OSA (n = 27) | Controls (n = 29) | P | |
---|---|---|---|
Disc hernia (at least one, %) | 28 | 26 | 0.92 |
Number of all disc hernias (n) | 0.6 ± 1.0 | 0.3 ± 0.5 | 0.92 |
Total endplate score (n) | 20.9 ± 7.8 | 20.8 ± 9.7 | 0.38 |
Disc bulging (at least one, %) | 85 | 52 | < 0.01 |
Number of all disc bulgings (n) | 4.6 ± 3.7 | 1.7 ± 2.5 | < 0.01 |
Total Pfirrmann score (n) | 16.7 ± 4.7 | 13.2 ± 4.1 | < 0.01 |
Anterolisthesis (at least one, %) | 15 | 3 | 0.13 |
Anterolisthesis (mm) | 0.7 ± 1.8 | 0.1 ± 0.7 | 0.13 |
Retrolisthesis (at least one, %) | 12 | 3 | 0.28 |
Retrolisthesis (mm) | 0.3 ± 1.0 | 0.2 ± 1.1 | 0.28 |
Superior endplate disease (n) | 0.8 ± 1.6 | 0.7 ± 2.1 | 0.15 |
Inferior endplate disease (n) | 0.8 ± 1.3 | 0.7 ± 2.0 | 0.44 |
Superior Schmorl nodes (n) | 0.8 ± 1.2 | 0.9 ± 1.4 | 0.90 |
Inferior Schmorl nodes (n) | 0.4 ± 0.8 | 0.7 ± 1.1 | 0.56 |
Vertebral fatty degeneration (score between 0 and 18) | 7.8 ± 4.7 | 3.8 ± 3.7 | < 0.01 |
Anterior spondylophytes (n) | 2.7 ± 4.2 | 0.8 ± 2.1 | 0.01 |
Posterior spondylophytes (n) | 1.1 ± 2.4 | 0.4 ± 0.9 | 0.47 |
Disc height narrowing (mm) | 3.3 ± 2.1 | 3.0 ± 3.2 | 0.15 |
Annular high intensity zone (n) | 0.6 ± 1.2 | 0.3 ± 0.6 | 0.40 |
Analyses were adjusted for age, gender, BMI, smoking and cardiovascular disease. Data are presented as mean ± standard deviation.